[OFER-TRABEC] NAC: âRío Ortegaâ and âJuan Rodésâ Candidates in Breast

===
Boletín semanal de ofertas de empleo publico
http://administracion.gob.es/pag_Home/empleoBecas/empleo/boletinEmpleoPublico.html
===

---Procedencia:
Institución:IDIBELL
Contacto correo-e:mapujana@iconcologia.net
---
We seek for excellent and highly motivated investigators that are willing to join our research group by applying to a "Río Ortega" or "Juan Rodés" contract in the upcoming call "Acción Estratégica en Salud".

The Rio Hortega contracts re directed for research training of professionals with "Formación Sanitaria Especializada" (BIR, FIR, MIR o QUIR) and this year the program will include training and clinical activities.

The 'Juan Rodés' contracts are intended to incorporate professionals able to combine clinical and research activities in accredited Health Research Institutes, like ours (IDIBELL).

Our research group is situated within the Catalan Institute of Oncology (Bellvitge Institute for Biomedical Research, IDIBELL). The Institute offers strong interactive environment and various excellent opportunities for collaborative research exists within the institute and the surrounding Hospital area. Interested applicants are encouraged to apply with an email containing your curriculum vitae, and names and contact information of two references to Miguel Angel Pujana via e-mail: mapujana@iconcologia.net.

Web pages:
http://www.procure-ico.eu/ma-pujana-lab.html
http://www.cancersystemsbiology.cat/
http://ico.gencat.cat/es/recerca/Programa-ProCURE/


----------------
Información complementaria de la oferta:
Recent publications by the group are:

Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, Islam A, Prado X, Llorente A, Petit A, Vidal A, Català I, Soler T, Venturas G, Rojo-Sebastian A, Serra H, Cuadras D, Blanco I, Lozano J, Canals F, Sieuwerts AM, de Weerd V, Look MP, Puertas S, García N, Perkins AS, Bonifaci N, Skowron M, Gómez-Baldó L, Hernández V, Martínez-Aranda A, Martínez-Iniesta M, Serrat X, Cerón J, Brunet J, Barretina MP, Gil M, Falo C, Fernández A, Morilla I, Pernas S, Plà MJ, Andreu X, Seguí MA, Ballester R, Matias-Guiu X, Figueras A, Sánchez-Mut JV, Sánchez-Céspedes M, Cordero A, Gómez-Miragaya J, Palomero L, Gómez A, Gajewski TF, Cohen EE, Jesiotr M, Bodnar L, Quintela-Fandino M, López-Bigas N, Valdés-Mas R, Puente XS, Viñals F, Casanovas O, Graupera M, Hernández-Losa J, Ramón Y Cajal S, García-Alonso L, Saez-Rodriguez J, Esteller M, Sierra A, Martín-Martín N, Matheu A, Carracedo A, González-Suárez E, Nanjundan M,
Cortés J, Lázaro C, Odero MD, Martens JW, Moreno-Bueno G, Barcellos-Hoff MH, Villanueva A, Gomis RR, Pujana MA. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. Oncogene Dec 19 doi: 10.1038/onc.2016.427.

Serra-Musach J, Mateo F, Capdevila-Busquets E, de Garibay GR, Zhang X, Guha R, Thomas CJ, Grueso J, Villanueva A, Jaeger S, Heyn H, Vizoso M, Pérez H, Cordero A, Gonzalez-Suarez E, Esteller M, Moreno-Bueno G, Tjärnberg A, Lázaro C, Serra V, Arribas J, Benson M, Gustafsson M, Ferrer M, Aloy P, Pujana MA. Cancer network activity associated with therapeutic response and synergism. Genome Medicine 24;8(1):88.

Pujana MA. Integrating germline and somatic data towards a personalized cancer medicine. Trends in Molecular Medicine 20(8):413-5.